Determination of the Minimum Volume Required to Ensure Partial Liquid Ventilation in the Pig With Ards

Constantin, Jean Michel; Gindre, G; González, Daniel; Segrell-Therre, JD; Bazin, J. E.; Schoeffler, P.

doi:10.1097/00000542-199809230-00044

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…30 ml/kg Körpergewicht (gesunder Erwachsener) [12,13,18,41,60,78]. Dabei sollten die positiven Wirkungen von Perfluorkarbonen, wie sie für die TLV beschrieben sind, kombiniert mit konventionellen Beatmungstechniken den apparativen Aufwand vermindern und die klinische Einsatzfähigkeit begünstigen.…”

Section: Partial Liquid Ventilation (Plv) Partielle Flüssigkeitsbeatunclassified

Vom Isofluran zum Perfluorhexan? Perfluorkarbone – Therapiemöglichkeiten beim akuten Lungenversagen

et al. 2000

View full text Add to dashboard Cite

The introduction of Perfluorochemicals into medicine and especially into the treatment of severe lung injury is a fascinating scientific task. Many recall the famous experiments from Clark et al. in 1966 when he demonstrated "liquidventilation with perfluorocarbons" in the mammal species for the first time. After this hallmark, perfluorocarbons were subsequently introduced in research of acute lung injury by the techniques of Total- and Partial-Liquid-Ventilation (TLV; PLV). Perfluorocarbons (saturated organofluorids) have unique chemical and physical properties which made them attractive substances for intraalveolar application. The strong C-F bindings in the perfluorocarbon molecules are responsible for their chemical stability, biochemical inertness, high capacity to dissolve respiratory gases, low surface tension and high vapor pressures. Furthermore, the high density of the PFC lead to radio-opacity and their distribution to dependent lung areas. The efficacy of PFC liquid, applied by TLV/PLV has been demonstrated in numerous animal studies using different models of acute lung injury. Currently, several mechanisms of action of perfluorocarbon fluids in acute lung injury are discussed: recruitment of atelectatic alveoli, prevention of endexpiratory collapse of alveoli ("liquid PEEP"), redistribution of perfusion, oxygen transport, surfactant like effects and decrease of inflammation. Since total liquid ventilation has been used only in experimental models of lung injury, partial liquid ventilation has been introduced successfully into clinical trials (phase I-II). However, the results of the first randomised, controlled study of PLV in 90 adult patients suffering from severe respiratory failure (ALI/ARDS) showed no differences between PLV and conventional treatment. Furthermore, the instillation of relatively large amounts of liquid into the lungs poses several technical challenges and may be associated with complications such as liquithoraces, pneumothoraces and hypoxia. Since mammal lungs are evolutionary specialised to gas exchange using atmospheric oxygen, the application of liquids, even if they transport respiratory gases very well is not physiologic. To overcome these unwanted side effects, we developed a technique of perfluorocarbon vaporisation in analogy to the application of inhalation anaesthetic agents. After resolving some technical issues, this application technique was used successfully in an animal model of acute lung injury. Vaporisation of perfluorohexane in a concentration of 18 Vol.% of inspired gas improved significantly oxygenation and lung compliance. Though these results are promising, mechanisms of action, dose-efficacy relation, surfactant-perfluorocarbon interaction or anti-inflammatory effects of vaporised perfluorohexane are still unclear. These questions need to be clarified before this technique can be applied clinically. However, the inhalation of vapor, a technique already familiar to anaesthesiologists should avoid risks of large amounts of fluids in the bronchoalveolar spac...

show abstract

Section: Partial Liquid Ventilation (Plv) Partielle Flüssigkeitsbeatunclassified

Vom Isofluran zum Perfluorhexan? Perfluorkarbone – Therapiemöglichkeiten beim akuten Lungenversagen

et al. 2000

View full text Add to dashboard Cite

show abstract

“…In an oleic acid lung injury model, Constantin compared the gas exchange efficacy of PLV after instillation of 5, 10, or 15 mL.kg ' Rimar 101 while using a "best PEEP" level based on the LIP. Oxygenation was not significantly better with a PIC dose above 10 mL.kg' (509,510).…”

Section: 6tmentioning

confidence: 80%

Perfluorocarbon liquid ventilation

Degraeuwe

View full text Add to dashboard Cite

People interested in the research are advised to contact the author for the final version of the publication, or visit the DOI to the publisher's website.• The final author version and the galley proof are versions of the publication after peer review.• The final published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the "Taverne" license above, please follow below link for the End User Agreement:

show abstract

Determination of the Minimum Volume Required to Ensure Partial Liquid Ventilation in the Pig With Ards

Cited by 2 publications

References 0 publications

Vom Isofluran zum Perfluorhexan? Perfluorkarbone – Therapiemöglichkeiten beim akuten Lungenversagen

Vom Isofluran zum Perfluorhexan? Perfluorkarbone – Therapiemöglichkeiten beim akuten Lungenversagen

Perfluorocarbon liquid ventilation

Contact Info

Product

Resources

About